RhoB抑制慢性粒细胞白血病细胞的生长-东南大学学报医学版

RhoB抑制慢性粒细胞白血病细胞的生长

单位：江苏省苏州大学唐仲英血液学研究中心

分类号：

出版年·卷·期（页码）：2012·31·第五期（537-542）

摘要：

目的研究RhoB对慢性粒细胞白血病（chronic myeloid leukemia，CML）细胞增殖能力的影响。方法用PCR方法扩增RhoB编码区并构建几种RhoB脂类修饰突变体。以慢病毒为载体携带RhoB及其突变体在CML细胞中过表达后，检测细胞增殖能力，并分析细胞的周期进程。结果过表达RhoB能抑制MEG-01细胞及CML患者CD34+细胞的增殖；脂类修饰缺失的RhoBC193G不能抑制CML细胞的增殖；单独进行法尼基（F）修饰和单独进行牻牛儿基牻牛儿基（GG）修饰的RhoB均可抑制CML细胞的增殖；过表达RhoB及其单种脂类修饰变体将CML细胞阻滞于G2/M期。结论 RhoB需要F或GG类型的脂类修饰抑制CML细胞的生长并将CML细胞阻滞于G2/M期。

Objective: To study the effect of RhoB on the proliferation of chronic myeloid leukemia (CML) cells. Methods: Wild type RhoB and its lipid modification variants were amplified with PCR; lentiviral vectors were constructed to overexpress RhoB and its variants in CML cells; effect on the growth of CML cell and the alteration of cell cycle were analyzed. Results: Overexpression of RhoB in MEG-01 and CD34+ cells from CML patients reduced their proliferation. The lipid modification deficient variant RhoBC193G could not inhibit the growth of CML cells. Both farnesylated (F) and geranylgeranylated (GG) RhoB (RhoB-F and RhoB-GG) decreased the proliferation ability of CML cells. RhoB, RhoB-F and RhoB-GG transduced CML cells resided more at G2/M phase compared with control or RhoBC193G transducted cells. Conclusion: RhoB required lipid modification to suppress the growth of CML cells, which was correlated with the arrest of cells at G2/M.

参考文献：

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录